Twelve days ago, a federal judicial panel issued an order that will reshape how thousands of injured patients pursue justice against two of the world’s largest medical device manufacturers. On June 5, 2026, the U.S. Judicial Panel on Multidistrict Litigation formally established MDL 3181, centralizing federal spinal cord stimulator lawsuit claims against Boston Scientific and Abbott Laboratories in the Central District of California. If you or someone you love suffered injuries from a spinal cord stimulator device — lead migration, electrical burns, nerve damage, or worse — this development directly affects your legal options right now.
What Is MDL 3181 and Why Does It Matter?
The JPML’s June 5, 2026 order created a proceeding officially titled IN RE: Abbott Laboratories and Boston Scientific Corporation Spinal Cord Stimulator Products Liability Litigation. The case has been assigned to Judge Josephine L. Staton in the Central District of California, one of the nation’s busiest federal courts for complex civil litigation. The initial transfer order consolidates 23 Boston Scientific spinal cord stimulator lawsuits drawn from nine different federal districts across the country.
The MDL formation came after plaintiffs filed a consolidation motion on February 20, 2026, arguing that the cases shared overlapping factual questions about regulatory compliance, device performance, and failure to warn. At the time that motion was filed, at least 15 federal lawsuits were already pending, and an estimated 400 additional injured patients had already retained legal counsel. That number is almost certainly higher today. Critically, the JPML declined to create a broader industry-wide MDL that would have swept in Medtronic and Nevro devices — those claims will proceed on separate tracks, keeping MDL 3181 focused squarely on Boston Scientific and Abbott products.
The Injuries Driving the Spinal Cord Stimulator Lawsuit Wave
Spinal cord stimulators are implanted devices designed to manage chronic pain by delivering mild electrical impulses to the spinal cord. When they work as intended, they can meaningfully reduce reliance on opioids and improve quality of life. When they fail, the consequences can be catastrophic and permanent. The injuries alleged across the spinal cord stimulator lawsuit filings consolidated into MDL 3181 include:
- Lead migration — the electrode leads shift from their implanted position, delivering stimulation to unintended areas of the spinal cord
- Lead fracture — leads break inside the body, requiring surgical revision
- Painful electrical shocks — patients report sudden, uncontrolled jolts of electricity
- Thermal burns — overheating components cause internal tissue damage
- Autonomic dysfunction — disruption of involuntary body systems including heart rate, blood pressure, and bladder function
- Nerve damage and neurological injury — permanent loss of sensation or motor function
- Worsening of original pain condition
- Paralysis — in the most severe reported cases
- Device infection requiring explant surgery
Revision surgery to reposition, repair, or remove a malfunctioning spinal cord stimulator is itself a high-risk procedure. Many plaintiffs allege that a device meant to reduce suffering instead left them permanently worse off than before implantation. If you have experienced any of these complications, using a medical malpractice calculator can help you understand the preliminary compensation range your injuries may support.
The FDA’s Alarming Adverse Event Record
The regulatory history behind this spinal cord stimulator lawsuit wave is striking. According to an Associated Press investigation reviewed in the litigation record, FDA’s MAUDE adverse event database received over 80,000 injury reports tied to spinal cord stimulator devices between 2008 and 2018 alone — placing SCS devices among the top three most-reported medical devices for adverse events across that entire decade. Complaints filed in the MDL further allege that the FDA received nearly 500 death reports associated with these devices, alongside more than 40 separate product recalls.
The complication rate extends beyond individual reports. Public Citizen’s analysis of the clinical literature found that approximately 30 to 40 percent of patients who receive spinal cord stimulators experience complications. That is not a rare-outcome scenario — it is a systemic pattern that plaintiffs argue manufacturers knew about and failed to adequately disclose to prescribing physicians or patients.
| Data Point | Figure | Source |
|---|---|---|
| FDA MAUDE adverse event reports (2008–2018) | 80,000+ | AP Investigation / FDA MAUDE Database |
| Death reports received by FDA (SCS devices) | ~500 | MDL 3181 Complaint Allegations |
| SCS product recalls on record | 40+ | MDL 3181 Complaint Allegations |
| Patients experiencing complications (est.) | 30–40% | Public Citizen Analysis |
| Abbott 2023 Class 1 Recall — devices affected | 155,000+ | FDA / Wisner Baum |
| MRI-mode incidents tied to Abbott recall | 186 incidents / 73 injuries | FDA Recall Database |
| Australia TGA adverse event reports | 2,000+ | Australian TGA Records |
| Federal lawsuits pending at MDL motion filing | 15+ | JPML Filing, Feb. 20, 2026 |
| Injured patients with retained counsel (as of filing) | ~400 | JPML Filing, Feb. 20, 2026 |
| Initial cases transferred into MDL 3181 | 23 | JPML Order, June 5, 2026 |
Abbott’s Class 1 Recall and the PMA Supplement Allegations
Abbott’s legal exposure in MDL 3181 is anchored in part by a 2023 Class 1 FDA recall — the agency’s most serious recall classification, reserved for situations where there is a reasonable probability that use of the device will cause serious injury or death. That recall covered more than 155,000 Abbott Proclaim and Infinity series spinal cord stimulator devices after a Bluetooth and MRI mode lock-in defect was identified. The FDA’s recall database documents at least 186 separate incidents and 73 injuries tied to that specific defect. The Abbott spinal cord stimulator lawsuit allegations go further: plaintiffs claim that defective Bluetooth circuit components caused battery drainage, dangerous overheating, and unintended electrical stimulation — and that Abbott’s internal response was to characterize a hardware defect as a software issue in communications to regulators and the public.
Both Abbott and Boston Scientific face a broader regulatory allegation that threads through the entire MDL: the claim that manufacturers exploited the FDA’s PMA (Premarket Approval) supplement pathway to make significant design changes to their devices without conducting new clinical trials. Under standard PMA rules, major design modifications require independent safety and efficacy testing. The PMA supplement process was intended for minor modifications. Plaintiffs allege that by routing substantial design changes through the supplement pathway, manufacturers avoided the clinical scrutiny that could have caught device failures before they harmed patients. This allegation mirrors tactics seen in other high-profile device mass torts and gives the MDL a strong regulatory-fraud dimension that may increase settlement values across the litigation. If a family has lost someone due to these device failures, a wrongful death calculator can provide an early estimate of potential damages.
MDL 3181 vs. a Class Action: What Injured Patients Need to Know
One of the most common misconceptions about mass tort litigation is that an MDL is the same as a class action. It is not, and the distinction matters enormously for your individual case. In a class action, all plaintiffs share a single unified claim and receive an equal or formulaic share of any recovery. In MDL 3181, each spinal cord stimulator lawsuit filed by an individual plaintiff remains a separate case with its own facts, injuries, and damages. The MDL process simply moves all of those individual cases before one judge for coordinated pretrial proceedings — discovery, motions practice, and early case management — to avoid duplicative effort across dozens of courts.
What this means practically: your individual damages — your specific injuries, your medical costs, your lost income, your pain and suffering — still drive the value of your claim. Cases involving paralysis, nerve damage, or extensive revision surgeries will have different compensation ranges than cases involving short-term device malfunction. The MDL structure enables more efficient litigation and often accelerates global settlement negotiations, but every plaintiff retains their individual right to trial if a settlement is not reached. To understand what your specific injuries may be worth within this framework, a personal injury settlement calculator can help you benchmark your situation against comparable injury categories.
Who Qualifies for the Spinal Cord Stimulator Lawsuit?
Attorneys are actively accepting new cases for MDL 3181 and related state-court spinal cord stimulator lawsuit filings. Based on the current litigation landscape, you may qualify if you meet the following general criteria:
- You received a Boston Scientific or Abbott (St. Jude Medical) spinal cord stimulator implant
- You experienced device complications including lead migration, lead fracture, electrical shocks, burns, infection, nerve damage, autonomic dysfunction, or worsening pain
- You required revision surgery, device removal, or hospitalization as a result of device failure
- Your device was part of the 2023 Abbott Class 1 Recall covering Proclaim or Infinity series devices
- You suffered permanent neurological injury or functional impairment attributable to your SCS device
It is important to act promptly. Although MDL 3181 was only formed on June 5, 2026, individual statutes of limitations continue to run based on when you knew or should have known about your injury. Most states apply a discovery rule, but waiting too long can eliminate your right to file entirely. The litigation is still in early stages — no bellwether verdicts have been reached and no global settlement has been announced — which means this remains a favorable window to enter the case while it is being actively shaped.
Frequently Asked Questions About the Spinal Cord Stimulator Lawsuit MDL
What is MDL 3181 and when was it created?
MDL 3181, formally titled IN RE: Abbott Laboratories and Boston Scientific Corporation Spinal Cord Stimulator Products Liability Litigation, was created by the U.S. Judicial Panel on Multidistrict Litigation on June 5, 2026. It is assigned to Judge Josephine L. Staton in the Central District of California and consolidates federal spinal cord stimulator lawsuit claims against Boston Scientific and Abbott for coordinated pretrial proceedings.
What injuries are covered in the spinal cord stimulator lawsuits?
The injuries alleged across MDL 3181 include lead migration, lead fracture, painful electrical shocks, thermal burns, autonomic dysfunction, neurological injury, nerve damage, worsening of chronic pain, infection requiring device removal, and paralysis. Any patient who experienced serious complications after receiving a Boston Scientific or Abbott SCS device may have grounds to file a claim.
What was Abbott’s 2023 Class 1 Recall about?
Abbott issued a Class 1 FDA recall in 2023 covering more than 155,000 Proclaim and Infinity series spinal cord stimulator devices. The recall was triggered by a Bluetooth and MRI mode lock-in defect linked to at least 186 incidents and 73 injuries. Plaintiffs in the spinal cord stimulator lawsuit allege that the underlying cause was a defective Bluetooth circuit hardware component that Abbott mischaracterized as a software issue.
How is an MDL different from a class action lawsuit?
Unlike a class action, where all plaintiffs share a single claim and receive equal or formulaic compensation, an MDL keeps each plaintiff’s case individual. MDL 3181 consolidates spinal cord stimulator lawsuits before one judge only for pretrial efficiency — your specific injuries, medical costs, lost income, and suffering still determine your individual damages. This structure typically benefits plaintiffs with serious injuries more than a class action would.
How much compensation could a spinal cord stimulator lawsuit be worth?
Compensation in individual spinal cord stimulator lawsuit cases varies widely based on injury severity, required surgeries, permanent impairment, lost wages, and pain and suffering. Cases involving paralysis, permanent nerve damage, or multiple revision surgeries typically involve significantly higher damages than cases involving temporary device malfunction. Because MDL 3181 has no bellwether verdicts yet, precise ranges are still developing — use our mass tort injury calculator on this site to generate a personalized preliminary estimate based on your injury profile.
Legal Disclaimer: The information provided on this page is for general informational purposes only and does not constitute legal advice, create an attorney-client relationship, or guarantee any specific legal outcome.
Related reading: personal injury settlement calculator
Related reading: medical malpractice calculator
Victoria Chambers is a mass tort and class action research analyst with extensive knowledge of multi-district litigation (MDL), defective product cases, dangerous drug lawsuits, and toxic exposure claims across the United States. Victoria is not an attorney and the information provided is for educational purposes only.